Cardiotoxicity after cancer treatment: a process map of the patient treatment journey.
Robyn A ClarkeTania S MarinAlexandra L McCarthyJulie BradleySuchi GroverRobyn PetersChristos S KarapetisJohn J AthertonBogda KoczwaraPublished in: Cardio-oncology (London, England) (2019)
Our results demonstrate that the clinical management of cancer patients with cardiotoxicity was variable and fragmented and not patient centered. This audit establishes practice gaps that can be addressed through the design of an evidence-based clinical pathway for cancer patients with, or at risk, of cardiotoxicity.